142 related articles for article (PubMed ID: 10717531)
1. Truncated adenomatous polyposis coli (APC) tumour suppressor protein can undergo tyrosine phosphorylation.
Norris AL; Clissold PM; Askham JM; Morrison EE; Moncur P; McCall SH; Coletta PL; Meredith DM; Markham AF
Eur J Cancer; 2000 Mar; 36(4):525-32. PubMed ID: 10717531
[TBL] [Abstract][Full Text] [Related]
2. The adenomatous polyposis coli (APC) tumour suppressor--genetics, function and disease.
Sieber OM; Tomlinson IP; Lamlum H
Mol Med Today; 2000 Dec; 6(12):462-9. PubMed ID: 11099951
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of the tumor suppressor adenomatous polyposis coli (APC) by the cyclin-dependent kinase p34.
Trzepacz C; Lowy AM; Kordich JJ; Groden J
J Biol Chem; 1997 Aug; 272(35):21681-4. PubMed ID: 9268294
[TBL] [Abstract][Full Text] [Related]
4. [From gene to disease; the APC gene and familial adenomatous polyposis coli].
van der Luijt RB; Tops CM; Vasen HF
Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2007-9. PubMed ID: 11072519
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer.
Ruiz-Ponte C; Vega A; Carracedo A; Barros F
Hum Mutat; 2001 Oct; 18(4):355. PubMed ID: 11668620
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the adenomatous polyposis coli protein and its possible regulatory effects in cells.
Bhattacharya G; Boman BM
Biochem Biophys Res Commun; 1995 Mar; 208(1):103-10. PubMed ID: 7887918
[TBL] [Abstract][Full Text] [Related]
7. Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene.
Rubinfeld B; Albert I; Porfiri E; Munemitsu S; Polakis P
Cancer Res; 1997 Oct; 57(20):4624-30. PubMed ID: 9377578
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated Apc mutations in Mlh1-/- Apc1638N mice reveal a mutational signature of Mlh1 deficiency.
Kuraguchi M; Edelmann W; Yang K; Lipkin M; Kucherlapati R; Brown AM
Oncogene; 2000 Nov; 19(50):5755-63. PubMed ID: 11126362
[TBL] [Abstract][Full Text] [Related]
9. Adenomatous polyposis coli (APC) membrane recruitment 3, a member of the APC membrane recruitment family of APC-binding proteins, is a positive regulator of Wnt-β-catenin signalling.
Brauburger K; Akyildiz S; Ruppert JG; Graeb M; Bernkopf DB; Hadjihannas MV; Behrens J
FEBS J; 2014 Feb; 281(3):787-801. PubMed ID: 24251807
[TBL] [Abstract][Full Text] [Related]
10. Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation.
Scott RJ; Froggatt NJ; Trembath RC; Evans DG; Hodgson SV; Maher ER
Hum Mol Genet; 1996 Dec; 5(12):1921-4. PubMed ID: 8968744
[TBL] [Abstract][Full Text] [Related]
11. Chain-terminating mutations in the APC gene lead to alterations in APC RNA and protein concentration.
Gismondi V; Stagnaro P; Pedemonte S; Biticchi R; Presciuttini S; Grammatico P; Sala P; Bertario L; Groden J; Varesco L
Genes Chromosomes Cancer; 1998 Aug; 22(4):278-86. PubMed ID: 9669665
[TBL] [Abstract][Full Text] [Related]
12. Nine novel APC mutations in Italian FAP patients.
Resta N; Stella A; Susca F; Montera M; Gentile M; Cariola F; Prete F; Tenconi R; Tibiletti MG; Logrieco G; Mattina T; Andriulli G; Caruso ML; Fiorente P; Russo S; Caputi-Jambrenghi O; Mareni C; Guanti G
Hum Mutat; 2001 May; 17(5):434-5. PubMed ID: 11317365
[TBL] [Abstract][Full Text] [Related]
13. Association between wild type and mutant APC gene products.
Su LK; Johnson KA; Smith KJ; Hill DE; Vogelstein B; Kinzler KW
Cancer Res; 1993 Jun; 53(12):2728-31. PubMed ID: 8389242
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.
Miyaki M; Konishi M; Kikuchi-Yanoshita R; Enomoto M; Igari T; Tanaka K; Muraoka M; Takahashi H; Amada Y; Fukayama M
Cancer Res; 1994 Jun; 54(11):3011-20. PubMed ID: 8187091
[TBL] [Abstract][Full Text] [Related]
15. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.
Crabtree M; Sieber OM; Lipton L; Hodgson SV; Lamlum H; Thomas HJ; Neale K; Phillips RK; Heinimann K; Tomlinson IP
Oncogene; 2003 Jul; 22(27):4257-65. PubMed ID: 12833148
[TBL] [Abstract][Full Text] [Related]
16. Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein.
Homma MK; Li D; Krebs EG; Yuasa Y; Homma Y
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5959-64. PubMed ID: 11972058
[TBL] [Abstract][Full Text] [Related]
17. NH2-terminal deletion of beta-catenin results in stable colocalization of mutant beta-catenin with adenomatous polyposis coli protein and altered MDCK cell adhesion.
Barth AI; Pollack AL; Altschuler Y; Mostov KE; Nelson WJ
J Cell Biol; 1997 Feb; 136(3):693-706. PubMed ID: 9024698
[TBL] [Abstract][Full Text] [Related]
18. Dominant negative effect of the APC1309 mutation: a possible explanation for genotype-phenotype correlations in familial adenomatous polyposis.
Dihlmann S; Gebert J; Siermann A; Herfarth C; von Knebel Doeberitz M
Cancer Res; 1999 Apr; 59(8):1857-60. PubMed ID: 10213492
[TBL] [Abstract][Full Text] [Related]
19. Exon eight APC mutations account for a disproportionate number of familial adenomatous polyposis families.
Koorey DJ; McCaughan GW; Trent RJ; Gallagher ND
Hum Mutat; 1994; 3(1):12-8. PubMed ID: 8118461
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients.
Kohler EM; Brauburger K; Behrens J; Schneikert J
Oncogene; 2010 Mar; 29(11):1663-71. PubMed ID: 19966865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
